サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1266370

大腸内視鏡の世界市場：用途別（大腸がん、潰瘍性大腸炎、クローンズ病、その他）、エンドユーザー別（病院、外来手術センター、その他）：機会分析および産業予測、2021年～2031年

Colonoscope Market By Application (Colorectal Cancer, Ulcerative Colitis, Crohns Disease, Others), By End User (Hospitals, Ambulatory Surgery Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 220 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
大腸内視鏡の世界市場：用途別（大腸がん、潰瘍性大腸炎、クローンズ病、その他）、エンドユーザー別（病院、外来手術センター、その他）：機会分析および産業予測、2021年～2031年
出版日: 2023年02月01日
発行: Allied Market Research
ページ情報: 英文 220 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の大腸内視鏡市場は、2021年に12億米ドルと評価され、2022年から2031年にかけてCAGR7.6%で成長し、2031年には25億米ドルに達すると予測されます。

大腸内視鏡は、大腸を検査するために肛門から挿入される柔軟な光ファイバー器具です。炎症性腸疾患や大腸がんなどの消化器系疾患の診断に有用です。また、大腸がんの治療や予防にも役立ちます。ヘルスケアプロバイダーは、がんのスクリーニングのために、中高年の方に定期的な大腸内視鏡検査をお勧めしています。ほとんどの方が、定期的ながん検診のために初めて大腸内視鏡検査を受けられます。統計的に、大腸がんの発症リスクは年齢が上がるにつれて高くなるため、米国がん協会では少なくとも45歳までに定期的な検診を受けることを推奨しています。また、大腸内視鏡では、生検やがん病巣の切除を行うために、専用のツールを器具ポートから導入するなどの治療行為も可能です。大腸内視鏡を使って大腸粘膜に注入された食物に対する局所反応を利用した皮膚プリックテストの腸管版は、より良い予測値を持つと思われるが、広く適用されてはいないです。

大腸内視鏡市場の成長は、大腸関連疾患の発生率の増加、高齢化社会におけるヘルスケアサービスの需要の増加、大腸内視鏡分野の継続的な開発によってもたらされます。また、高齢者人口の増加や、大腸疾患の診断を容易にするための大腸内視鏡システムの導入が急増しており、市場成長に大きく貢献すると期待されています。さらに、世界の大腸内視鏡市場の成長は、大腸内視鏡の進歩の増加などの要因によって大きく左右され、市場の成長を牽引することが確実視されています。世界の大腸内視鏡市場の著名なプレーヤーは、市場での地位を強化し、競合環境を維持するために、製品の発売、買収、大腸内視鏡の進歩のための研究開発への投資など、様々な戦略を選択しています。例えば、2022年、SMART Medical Systems Ltd.は、510（k）クリアでもあるOlympusのPCF大腸内視鏡シリーズをベースにしたG-EYE大腸内視鏡のFDA追加クリアを発表しました。これにより、米国では、オリンパス、富士フイルム、ペンタックスメディカルの3社の内視鏡ブランドから、一般的に使用されている大腸内視鏡が使用できるようになります。

大腸内視鏡の利点に関する認知度の向上、検診での使用率の上昇、大腸関連疾患を患う患者数の急増などが、市場の成長を促す重要な要因となっています。しかし、大腸内視鏡検査中の合併症のリスクや装置のコストが高いことが、市場の成長を制限しています。逆に、新製品や先進的な製品の導入は、予測期間中に市場力学を変化させ、市場成長に有利な機会を提供すると予想されます。医療機器分野における広範な研究開発活動は、医療インフラの大幅な改善とともに、市場拡大のための新たな道を開くと予測されます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • トップインパクトファクター
    • トップインベストメントポケット
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入業者の脅威
    • ライバルの強さ
  • 市場力学
    • 促進要因
      • 大腸がんの有病率の増加
      • 大腸内視鏡イメージングにおける技術進歩の高まり
      • 低侵襲手術への嗜好の高まり
    • 抑制要因
      • 大腸内視鏡の処置に伴う高いリスク
    • 機会
      • ヘルスケア施設向け大腸内視鏡の利用が急増
  • COVID-19市場への影響度分析

第4章 大腸内視鏡市場：応用分野別

  • 概要
    • 市場規模・予測
  • 大腸がん（Colorectal Cancer
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • 潰瘍性大腸炎（Ulcerative Colitis
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • クローンス病
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • その他
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析

第5章 大腸内視鏡の市場：エンドユーザー別

  • 概要
    • 市場規模・予測
  • 病院
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • 外来手術センター
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析
  • その他
    • 主な市場動向、成長要因、機会について
    • 市場規模・予測：地域別
    • 市場シェア分析：国別分析

第6章 大腸内視鏡の市場：地域別

  • 概要
    • 市場規模・予測：地域別
  • 北米
    • 主な動向と機会
    • 市場規模・予測：アプリケーション別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • 米国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • カナダ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • メキシコ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
  • 欧州
    • 主な動向と機会
    • 市場規模・予測：アプリケーション別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • ドイツ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • フランス
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • 英国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • イタリア
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • スペイン
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • その他欧州
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
  • アジア太平洋地域
    • 主な動向と機会
    • 市場規模・予測：アプリケーション別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • 中国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • 日本
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • インド
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • オーストラリア
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • 韓国
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • その他アジア太平洋地域
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
  • LAMEA
    • 主な動向と機会
    • 市場規模・予測：アプリケーション別
    • 市場規模・予測：エンドユーザー別
    • 市場規模・予測：国別
      • ブラジル
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • サウジアラビア
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • 南アフリカ
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別
      • LAMEAの残りの地域
      • 主な市場動向、成長要因、機会について
      • 市場規模・予測：アプリケーション別
      • 市場規模・予測：エンドユーザー別

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • トップ企業のポジショニング、2021年

第8章 企業プロファイル

  • Olympus Corporation
  • Stryker Corporation
  • Pentax Medical
  • Fujifilm Holdings
  • Medtronic plc
  • Boston Scientific Corporation
  • Endomed Systems
  • Sonoscape Medical Corp.
  • Ambu A/S
  • Endofresh
図表

LIST OF TABLES

  • TABLE 01. GLOBAL COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 02. COLONOSCOPE MARKET FOR COLORECTAL CANCER, BY REGION, 2021-2031 ($MILLION)
  • TABLE 03. COLONOSCOPE MARKET FOR ULCERATIVE COLITIS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 04. COLONOSCOPE MARKET FOR CROHNS DISEASE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 05. COLONOSCOPE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 06. GLOBAL COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 07. COLONOSCOPE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 08. COLONOSCOPE MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 09. COLONOSCOPE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 10. COLONOSCOPE MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. NORTH AMERICA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 12. NORTH AMERICA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 13. NORTH AMERICA COLONOSCOPE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. U.S. COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 15. U.S. COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 16. CANADA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 17. CANADA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 18. MEXICO COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 19. MEXICO COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 20. EUROPE COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 21. EUROPE COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 22. EUROPE COLONOSCOPE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 23. GERMANY COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 24. GERMANY COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 25. FRANCE COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 26. FRANCE COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 27. UK COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 28. UK COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 29. ITALY COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 30. ITALY COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 31. SPAIN COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 32. SPAIN COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 33. REST OF EUROPE COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 34. REST OF EUROPE COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 35. ASIA-PACIFIC COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 36. ASIA-PACIFIC COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 37. ASIA-PACIFIC COLONOSCOPE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 38. CHINA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 39. CHINA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 40. JAPAN COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 41. JAPAN COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 42. INDIA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 43. INDIA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. AUSTRALIA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 45. AUSTRALIA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 46. SOUTH KOREA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 47. SOUTH KOREA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 48. REST OF ASIA-PACIFIC COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 49. REST OF ASIA-PACIFIC COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 50. LAMEA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 51. LAMEA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 52. LAMEA COLONOSCOPE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 53. BRAZIL COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 54. BRAZIL COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 55. SAUDI ARABIA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 56. SAUDI ARABIA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 57. SOUTH AFRICA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 58. SOUTH AFRICA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 59. REST OF LAMEA COLONOSCOPE MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 60. REST OF LAMEA COLONOSCOPE MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 61. OLYMPUS CORPORATION: KEY EXECUTIVES
  • TABLE 62. OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • TABLE 63. OLYMPUS CORPORATION: PRODUCT SEGMENTS
  • TABLE 64. OLYMPUS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 65. OLYMPUS CORPORATION: KEY STRATERGIES
  • TABLE 66. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 67. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 68. STRYKER CORPORATION: PRODUCT SEGMENTS
  • TABLE 69. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 70. STRYKER CORPORATION: KEY STRATERGIES
  • TABLE 71. PENTAX MEDICAL: KEY EXECUTIVES
  • TABLE 72. PENTAX MEDICAL: COMPANY SNAPSHOT
  • TABLE 73. PENTAX MEDICAL: SERVICE SEGMENTS
  • TABLE 74. PENTAX MEDICAL: PRODUCT PORTFOLIO
  • TABLE 75. FUJIFILM HOLDINGS: KEY EXECUTIVES
  • TABLE 76. FUJIFILM HOLDINGS: COMPANY SNAPSHOT
  • TABLE 77. FUJIFILM HOLDINGS: SERVICE SEGMENTS
  • TABLE 78. FUJIFILM HOLDINGS: PRODUCT PORTFOLIO
  • TABLE 79. FUJIFILM HOLDINGS: KEY STRATERGIES
  • TABLE 80. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 81. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 82. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 83. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 84. MEDTRONIC PLC: KEY STRATERGIES
  • TABLE 85. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 86. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 87. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
  • TABLE 88. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 89. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 90. ENDOMED SYSTEMS: KEY EXECUTIVES
  • TABLE 91. ENDOMED SYSTEMS: COMPANY SNAPSHOT
  • TABLE 92. ENDOMED SYSTEMS: PRODUCT SEGMENTS
  • TABLE 93. ENDOMED SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 94. SONOSCAPE MEDICAL CORP.: KEY EXECUTIVES
  • TABLE 95. SONOSCAPE MEDICAL CORP.: COMPANY SNAPSHOT
  • TABLE 96. SONOSCAPE MEDICAL CORP.: SERVICE SEGMENTS
  • TABLE 97. SONOSCAPE MEDICAL CORP.: PRODUCT PORTFOLIO
  • TABLE 98. AMBU A/S: KEY EXECUTIVES
  • TABLE 99. AMBU A/S: COMPANY SNAPSHOT
  • TABLE 100. AMBU A/S: PRODUCT SEGMENTS
  • TABLE 101. AMBU A/S: PRODUCT PORTFOLIO
  • TABLE 102. AMBU A/S: KEY STRATERGIES
  • TABLE 103. ENDOFRESH: KEY EXECUTIVES
  • TABLE 104. ENDOFRESH: COMPANY SNAPSHOT
  • TABLE 105. ENDOFRESH: PRODUCT SEGMENTS
  • TABLE 106. ENDOFRESH: SERVICE SEGMENTS
  • TABLE 107. ENDOFRESH: PRODUCT PORTFOLIO
  • TABLE 108. ENDOFRESH: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. COLONOSCOPE MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF COLONOSCOPE MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN COLONOSCOPE MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCOLONOSCOPE MARKET
  • FIGURE 10. COLONOSCOPE MARKET, BY APPLICATION, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR COLORECTAL CANCER, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR ULCERATIVE COLITIS, BY COUNTRY 2021-2031(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR CROHNS DISEASE, BY COUNTRY 2021-2031(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COLONOSCOPE MARKET, BY END USER, 2021(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY 2021-2031(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF COLONOSCOPE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COLONOSCOPE MARKET BY REGION, 2021
  • FIGURE 20. U.S. COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 21. CANADA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 22. MEXICO COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 23. GERMANY COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. FRANCE COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. UK COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. ITALY COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. SPAIN COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. REST OF EUROPE COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. CHINA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. JAPAN COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. INDIA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. AUSTRALIA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. SOUTH KOREA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. REST OF ASIA-PACIFIC COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. BRAZIL COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. SAUDI ARABIA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. SOUTH AFRICA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. REST OF LAMEA COLONOSCOPE MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 43. COMPETITIVE DASHBOARD
  • FIGURE 44. COMPETITIVE HEATMAP: COLONOSCOPE MARKET
  • FIGURE 45. TOP PLAYER POSITIONING, 2021
  • FIGURE 46. OLYMPUS CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 47. OLYMPUS CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 48. OLYMPUS CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 49. STRYKER CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 50. STRYKER CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 51. STRYKER CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 52. FUJIFILM HOLDINGS: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 53. FUJIFILM HOLDINGS: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 54. FUJIFILM HOLDINGS: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 55. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 57. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 58. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 59. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 60. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 61. AMBU A/S: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 62. AMBU A/S: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. AMBU A/S: REVENUE SHARE BY REGION, 2022 (%)
目次
Product Code: A07073

The global colonoscope market was valued at $1.2 billion in 2021, and is projected to reach $2.5 billion by 2031, growing at a CAGR of 7.6% from 2022 to 2031.  

A colonoscope is a flexible fiber-optic instrument inserted through the anus to examine the colon. It is helpful for diagnosing gastrointestinal diseases, such as inflammatory bowel disease and colon cancer. It can also help treat and prevent colon cancer. Healthcare providers recommend routine colonoscopies for middle-aged and older adults to screen for cancer. Most people have their first colonoscopy for routine cancer screening. Statistically, the risk of developing colorectal cancer goes up as age increases, which is why the American Cancer Society recommends regular screening at least by the age of 45. The colonoscope also allows for therapeutic actions like a dedicated tool could be introduced through the instrument port to perform a biopsy or removal of cancerous lesions. A gut version of skin prick testing using local reactions to food injected into the colonic mucosa via the colonoscope appears to have a better predictive value but is not widely applied.  

The growth of the colonoscopes market is driven by an increase in incidence of colon related diseases, rise in demand for healthcare services for the aging population and continuous developments in the field of colonoscopy. Moreover, rise in geriatric population and surge in adoption of colonoscope systems to facilitate better diagnosis of colon diseases is expected to notably contribute toward the market growth. Furthermore, the global colonoscopes market growth is largely driven by factors such as an increase in advancements of colonoscope which is surely expected to lead the growth of the market. Prominent players in the global colonoscopes market have opted various strategies such as product launch, acquisition, and investments in R&D for advancement in colonoscopes to strengthen their position in the market and sustain the competitive environment. For instance, in 2022, SMART Medical Systems Ltd., announced an additional FDA clearance for its G-EYE Colonoscope which is based on Olympus' PCF colonoscope series which is also 510(k) cleared. With this additional FDA clearance, G-EYE is available for use in the U.S. market on the commonly used colonoscope models of all three leading endoscopy brands namely OLYMPUS, FUJIFILM, and PENTAX Medical.  

A significant increase in awareness about the advantages of colonoscope, rise in the usage of this device in the screening, and surge in the number of patients suffering from colon related diseases are some of the other key factors driving the growth of the market. However, risks of complications during the colonoscopy and high cost of the device restricts the market growth. Conversely, the introduction of new and advanced products has changed the market dynamics during the forecast period and is expected to provide lucrative opportunities for the growth of the market. Extensive R&D activities in the field of medical devices along with significant improvement in medical infrastructure are anticipated to open new avenues for the expansion of the market.  

The global colonoscopes market is segmented on the basis of application, end user and region. On the basis of application, the market is divided into colorectal cancer, ulcerative colitis, Crohns disease and others. On the basis of end user, the market is categorized into hospitals, ambulatory surgery centers and others. Region wise, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).  

Major companies profiled in the report include: Olympus Corporation, Stryker Corporation, FUJIFILM Holdings Corporation, Medtronic Plc, Boston Scientific Corporation, PENTAX Medical, Endomed System, Sonoscape Medical Corporation, Ambu A/S, and Endofresh. 

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the colonoscope market analysis from 2021 to 2031 to identify the prevailing colonoscope market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the colonoscope market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global colonoscope market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Application

  • Colorectal Cancer
  • Ulcerative Colitis
  • Crohns Disease
  • Others

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Stryker Corporation
  • Medtronic plc
  • Pentax Medical
  • Olympus Corporation
  • Fujifilm Holdings
  • Sonoscape Medical Corp.
  • Ambu A/S
  • Endofresh
  • Boston Scientific Corporation
  • Endomed Systems

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Bargaining power of suppliers
    • 3.3.2. Bargaining power of buyers
    • 3.3.3. Threat of substitutes
    • 3.3.4. Threat of new entrants
    • 3.3.5. Intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the prevalence of colon cancer
      • 3.4.1.2. Rise in technological advancement in colonoscope imaging
      • 3.4.1.3. Increase in preference of population towards minimally invasive techniques
    • 3.4.2. Restraints
      • 3.4.2.1. High risks involved during the colonoscopy procedures
    • 3.4.3. Opportunities
      • 3.4.3.1. Surge in usage of colonoscope in healthcare facilities applications
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: COLONOSCOPE MARKET, BY APPLICATION

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Colorectal Cancer
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Ulcerative Colitis
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Crohns Disease
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country
  • 4.5. Others
    • 4.5.1. Key market trends, growth factors and opportunities
    • 4.5.2. Market size and forecast, by region
    • 4.5.3. Market share analysis by country

CHAPTER 5: COLONOSCOPE MARKET, BY END USER

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Hospitals
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Ambulatory Surgery Centers
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: COLONOSCOPE MARKET, BY REGION

  • 6.1. Overview
    • 6.1.1. Market size and forecast By Region
  • 6.2. North America
    • 6.2.1. Key trends and opportunities
    • 6.2.2. Market size and forecast, by Application
    • 6.2.3. Market size and forecast, by End User
    • 6.2.4. Market size and forecast, by country
      • 6.2.4.1. U.S.
      • 6.2.4.1.1. Key market trends, growth factors and opportunities
      • 6.2.4.1.2. Market size and forecast, by Application
      • 6.2.4.1.3. Market size and forecast, by End User
      • 6.2.4.2. Canada
      • 6.2.4.2.1. Key market trends, growth factors and opportunities
      • 6.2.4.2.2. Market size and forecast, by Application
      • 6.2.4.2.3. Market size and forecast, by End User
      • 6.2.4.3. Mexico
      • 6.2.4.3.1. Key market trends, growth factors and opportunities
      • 6.2.4.3.2. Market size and forecast, by Application
      • 6.2.4.3.3. Market size and forecast, by End User
  • 6.3. Europe
    • 6.3.1. Key trends and opportunities
    • 6.3.2. Market size and forecast, by Application
    • 6.3.3. Market size and forecast, by End User
    • 6.3.4. Market size and forecast, by country
      • 6.3.4.1. Germany
      • 6.3.4.1.1. Key market trends, growth factors and opportunities
      • 6.3.4.1.2. Market size and forecast, by Application
      • 6.3.4.1.3. Market size and forecast, by End User
      • 6.3.4.2. France
      • 6.3.4.2.1. Key market trends, growth factors and opportunities
      • 6.3.4.2.2. Market size and forecast, by Application
      • 6.3.4.2.3. Market size and forecast, by End User
      • 6.3.4.3. UK
      • 6.3.4.3.1. Key market trends, growth factors and opportunities
      • 6.3.4.3.2. Market size and forecast, by Application
      • 6.3.4.3.3. Market size and forecast, by End User
      • 6.3.4.4. Italy
      • 6.3.4.4.1. Key market trends, growth factors and opportunities
      • 6.3.4.4.2. Market size and forecast, by Application
      • 6.3.4.4.3. Market size and forecast, by End User
      • 6.3.4.5. Spain
      • 6.3.4.5.1. Key market trends, growth factors and opportunities
      • 6.3.4.5.2. Market size and forecast, by Application
      • 6.3.4.5.3. Market size and forecast, by End User
      • 6.3.4.6. Rest of Europe
      • 6.3.4.6.1. Key market trends, growth factors and opportunities
      • 6.3.4.6.2. Market size and forecast, by Application
      • 6.3.4.6.3. Market size and forecast, by End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key trends and opportunities
    • 6.4.2. Market size and forecast, by Application
    • 6.4.3. Market size and forecast, by End User
    • 6.4.4. Market size and forecast, by country
      • 6.4.4.1. China
      • 6.4.4.1.1. Key market trends, growth factors and opportunities
      • 6.4.4.1.2. Market size and forecast, by Application
      • 6.4.4.1.3. Market size and forecast, by End User
      • 6.4.4.2. Japan
      • 6.4.4.2.1. Key market trends, growth factors and opportunities
      • 6.4.4.2.2. Market size and forecast, by Application
      • 6.4.4.2.3. Market size and forecast, by End User
      • 6.4.4.3. India
      • 6.4.4.3.1. Key market trends, growth factors and opportunities
      • 6.4.4.3.2. Market size and forecast, by Application
      • 6.4.4.3.3. Market size and forecast, by End User
      • 6.4.4.4. Australia
      • 6.4.4.4.1. Key market trends, growth factors and opportunities
      • 6.4.4.4.2. Market size and forecast, by Application
      • 6.4.4.4.3. Market size and forecast, by End User
      • 6.4.4.5. South Korea
      • 6.4.4.5.1. Key market trends, growth factors and opportunities
      • 6.4.4.5.2. Market size and forecast, by Application
      • 6.4.4.5.3. Market size and forecast, by End User
      • 6.4.4.6. Rest of Asia-Pacific
      • 6.4.4.6.1. Key market trends, growth factors and opportunities
      • 6.4.4.6.2. Market size and forecast, by Application
      • 6.4.4.6.3. Market size and forecast, by End User
  • 6.5. LAMEA
    • 6.5.1. Key trends and opportunities
    • 6.5.2. Market size and forecast, by Application
    • 6.5.3. Market size and forecast, by End User
    • 6.5.4. Market size and forecast, by country
      • 6.5.4.1. Brazil
      • 6.5.4.1.1. Key market trends, growth factors and opportunities
      • 6.5.4.1.2. Market size and forecast, by Application
      • 6.5.4.1.3. Market size and forecast, by End User
      • 6.5.4.2. Saudi Arabia
      • 6.5.4.2.1. Key market trends, growth factors and opportunities
      • 6.5.4.2.2. Market size and forecast, by Application
      • 6.5.4.2.3. Market size and forecast, by End User
      • 6.5.4.3. South Africa
      • 6.5.4.3.1. Key market trends, growth factors and opportunities
      • 6.5.4.3.2. Market size and forecast, by Application
      • 6.5.4.3.3. Market size and forecast, by End User
      • 6.5.4.4. Rest of LAMEA
      • 6.5.4.4.1. Key market trends, growth factors and opportunities
      • 6.5.4.4.2. Market size and forecast, by Application
      • 6.5.4.4.3. Market size and forecast, by End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

  • 8.1. Olympus Corporation
    • 8.1.1. Company overview
    • 8.1.2. Key Executives
    • 8.1.3. Company snapshot
    • 8.1.4. Operating business segments
    • 8.1.5. Product portfolio
    • 8.1.6. Business performance
    • 8.1.7. Key strategic moves and developments
  • 8.2. Stryker Corporation
    • 8.2.1. Company overview
    • 8.2.2. Key Executives
    • 8.2.3. Company snapshot
    • 8.2.4. Operating business segments
    • 8.2.5. Product portfolio
    • 8.2.6. Business performance
    • 8.2.7. Key strategic moves and developments
  • 8.3. Pentax Medical
    • 8.3.1. Company overview
    • 8.3.2. Key Executives
    • 8.3.3. Company snapshot
    • 8.3.4. Operating business segments
    • 8.3.5. Product portfolio
  • 8.4. Fujifilm Holdings
    • 8.4.1. Company overview
    • 8.4.2. Key Executives
    • 8.4.3. Company snapshot
    • 8.4.4. Operating business segments
    • 8.4.5. Product portfolio
    • 8.4.6. Business performance
    • 8.4.7. Key strategic moves and developments
  • 8.5. Medtronic plc
    • 8.5.1. Company overview
    • 8.5.2. Key Executives
    • 8.5.3. Company snapshot
    • 8.5.4. Operating business segments
    • 8.5.5. Product portfolio
    • 8.5.6. Business performance
    • 8.5.7. Key strategic moves and developments
  • 8.6. Boston Scientific Corporation
    • 8.6.1. Company overview
    • 8.6.2. Key Executives
    • 8.6.3. Company snapshot
    • 8.6.4. Operating business segments
    • 8.6.5. Product portfolio
    • 8.6.6. Business performance
    • 8.6.7. Key strategic moves and developments
  • 8.7. Endomed Systems
    • 8.7.1. Company overview
    • 8.7.2. Key Executives
    • 8.7.3. Company snapshot
    • 8.7.4. Operating business segments
    • 8.7.5. Product portfolio
  • 8.8. Sonoscape Medical Corp.
    • 8.8.1. Company overview
    • 8.8.2. Key Executives
    • 8.8.3. Company snapshot
    • 8.8.4. Operating business segments
    • 8.8.5. Product portfolio
  • 8.9. Ambu A/S
    • 8.9.1. Company overview
    • 8.9.2. Key Executives
    • 8.9.3. Company snapshot
    • 8.9.4. Operating business segments
    • 8.9.5. Product portfolio
    • 8.9.6. Business performance
    • 8.9.7. Key strategic moves and developments
  • 8.10. Endofresh
    • 8.10.1. Company overview
    • 8.10.2. Key Executives
    • 8.10.3. Company snapshot
    • 8.10.4. Operating business segments
    • 8.10.5. Product portfolio
    • 8.10.6. Key strategic moves and developments